[In vitro systems for the primary search for biologically active substances with carcinostatic action]
- PMID: 3053148
[In vitro systems for the primary search for biologically active substances with carcinostatic action]
Abstract
Improvement and development of new methods for primary screening of antitumour drugs in vitro are based on the data on the points open to injury in the tumour cell metabolism and on the evidence of the known carcinostatic drug mechanism. Further development of the primary screening methods should proceed, probably, in two main directions. Further improvement of the methods for cloning tumour cells in the semifluid nutrient media is of great interest. On the whole the creation of new test systems is a significant trend of the scientific screening.
Similar articles
-
Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity.Br J Cancer. 2001 May 18;84(10):1289-90. doi: 10.1054/bjoc.2001.1797. Br J Cancer. 2001. PMID: 11355935 Free PMC article. No abstract available.
-
Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.Clin Cancer Res. 2006 Sep 15;12(18):5557-69. doi: 10.1158/1078-0432.CCR-06-0536. Clin Cancer Res. 2006. PMID: 17000693
-
[Bacterial test-system for a primary screening of the substances with potential anti-cancer activity].Tsitol Genet. 2007 Jul-Aug;41(4):59-65. Tsitol Genet. 2007. PMID: 18030728 Russian.
-
[History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro].Bull Cancer. 1991;78(7):587-602. Bull Cancer. 1991. PMID: 1912670 Review. French.
-
New anticancer agents: in vitro and in vivo evaluation.In Vivo. 2005 Jan-Feb;19(1):1-7. In Vivo. 2005. PMID: 15796152 Review.